NCT03617497View on ClinicalTrials.gov

Prevalence of Epilepsy and Sleep Wake Disorders in Alzheimer Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Alzheimer DiseaseAlzheimer DementiaEpilepsySleep Wake Disorders
Interventions
DIAGNOSTIC_TEST

scalp EEG and polysomnography

48 hour 22 channel EEG with polysomnography

DIAGNOSTIC_TEST

scalp EEG with foramen ovale electrodes with polysomnography

long-term scalp EEG with additional foramen ovale electrodes with polysomnography

Trial Locations (1)

3000

University Hospitals Leuven, department of Neurology, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER